赫赛汀治疗人类表皮生长因子受体2高表达晚期乳腺癌30例OACSTPCD
Herceptin in Treating 30 Cases of High Expression HER-2 Advanced Breast Cancer
目的 观察赫赛汀治疗人类表皮生长因子受体2高表达晚期乳腺癌中的疗效及不良反应.方法 选择医院2009年2月至2011年8月收治的晚期乳腺癌患者60例,随机分为两组,每组30例.治疗组使用赫赛汀静脉注射,3周方案为首周剂量8 mg/kg,之后每3周给药6mg/kg,坚持用药12个月;对照组使用卡培他滨治疗,2 500 mg/(m2.d),连续治疗2周后停药1周,3周为1个疗程,患者根据情况连续治疗3~10个疗程.对患者进行良好护理,并观察治疗疗效和…查看全部>>
Objective To investigate the efficacy and adverse reactions of herceptin in the treatment of high expression HER - 2 advanced breast cancer. Methods Sixty patients with advanced breast cancer treated in our hospital from February 2009 to August 2011 were randomly divided into 2 groups, 30 cases in each group. The treatment group received herceptin by intravenous injection. The 3 - week regimen was 8 mg/kg at the first week and then 6 mg/kg every 3 weeks with…查看全部>>
顾建芬
浙江省绍兴人民医院乳腺甲状腺外科,浙江绍兴,312000
医药卫生
赫赛汀人类表皮生长因子受体2晚期乳腺癌观察护理
herceptinHER - 2advanced breast cancerobservationnursing care
《中国药业》 2012 (7)
54-55,2
评论